Novavax, Inc. (NVAX) Posts Narrower than Expected Q4 Loss
Novavax, Inc. (NASDAQ: NVAX) reported Q4 loss of $0.06, 3 cents better than the analyst estimate of ($0.09). Revenue for the quarter came in at $51 thousand versus the consensus estimate of $110 thousand.